[Multimodality treatment in high-risk and very high-risk prostate cancer: outcomes from international phase III randomized controlled trials].

Mathier, Etienne; Heusel, Astrid; Shelan, Mohamed (2022). [Multimodality treatment in high-risk and very high-risk prostate cancer: outcomes from international phase III randomized controlled trials]. Strahlentherapie und Onkologie, 198(10), pp. 962-965. Springer 10.1007/s00066-022-01968-5

[img] Text
s00066-022-01968-5.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (202kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Mathier, Etienne, Heusel, Astrid Elisabeth, Shelan, Mohamed

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1439-099X

Publisher:

Springer

Language:

German

Submitter:

Pubmed Import

Date Deposited:

24 Jun 2022 10:00

Last Modified:

05 Dec 2022 16:21

Publisher DOI:

10.1007/s00066-022-01968-5

PubMed ID:

35732920

BORIS DOI:

10.48350/170880

URI:

https://boris.unibe.ch/id/eprint/170880

Actions (login required)

Edit item Edit item
Provide Feedback